YourLawyer.com® 1-800-LAW-INFO (1-800-529-4636)

Parker Waichman Alonso LLP Headlines by Topic

Epilepsy Drugs

Another Valproate Study Sees Problems for Developing Fetus

Jul 22, 2009 | Parker Waichman Alonso LLP
Children exposed to valproate in-utero may exhibit  lower IQs as toddlers than children whose mothers took other epilepsy drugs, according to...

Suicide Warnings Approved for Epilepsy Drugs

May 6, 2009 | Parker Waichman Alonso LLP
Federal regulators have approved new suicide warnings for more than two dozen epilepsy drugs.  The Food & Drug Administration (FDA) had...

Valproate Shouldn't be Taken by Pregnant Women, Medical Groups Say

Apr 28, 2009 | Parker Waichman Alonso LLP
The epilepsy drug valproate (Depacon) should not be taken by pregnant women, according to new guidelines issued by American Academy of Neurology and...

Valproate During Pregnancy Linked to Children with Lower IQs

Apr 16, 2009 | Parker Waichman Alonso LLP
Valproate (sold under the brand names Depacon and Depakene) taken during pregnancy may cause children to have lower IQs, according to a new study...

Zonegran Linked to Blood Disorder

Feb 23, 2009 | Parker Waichman Alonso LLP
The epilepsy drug zonisamide, sold both generically and under the brand name Zonegran, can cause a serious blood disorder called metabolic acidosis,...

Valproate Use During Pregnancy Linked to Autism

Dec 2, 2008 | Parker Waichman Alonso LLP
Mothers who take the epilepsy drug valproate (sold under the brand names Depacon and Depakene) during pregnancy may face an increased risk of having...

Advisory Panel Rejects 'Black Box' Warnings of Suicide Risk on Epilepsy Drugs

Jul 11, 2008 | Parker Waichman Alonso LLP
An expert advisory panel refused a Food & Drug Administration (FDA) proposal to place a “Black Box”—the agency’s...

Epilepsy Drugs Targeted for Black Box Suicide Warning

Jul 8, 2008 | Parker Waichman Alonso LLP
Federal regulators want the makers of epilepsy drugs to add a black box warning to their labels about their association with suicidal thoughts and...

Neurontin Should Have Had Depression Warning, Neurologist Says

Jun 20, 2008 | Parker Waichman Alonso LLP
A British neurologist says he advised the maker of Neurontin to include a warning on its label about its potential to cause depression and...

New Suicide Warning for Epilepsy Drugs

Jun 12, 2008 | Parker Waichman Alonso LLP
United States drug reviewers just announced that epilepsy drugs are associated with a higher risk of suicidal thoughts and behavior.  The...

Page 1/2 [first] [prev] 1 2 [next] [last]

Defective Drugs
* Denotes required field.

Title

* First Name

* Last Name

* Email Address

* Phone Number

Cell Phone Number

Office Phone Number

Street Address

Apartment/Suite

City

State

Zip Code

Please provide the best method and times to contact you:

Date of birth of person injured
(mm-dd-yyyy):

Name of drug:

Date you started taking the drug (mm-yyyy):

Date you stopped taking the drug (mm-yyyy):

Please describe any side effects:

Other Info:

No Yes, I agree to the Parker Waichman Alonso LLP disclaimers.Click here to review all.

Yes, I would like to receive the Parker Waichman Alonso LLP monthly newsletter, InjuryAlert.

please do not fill out the field below.

Home | Defective Drugs | Medical Devices | Toxic Substances | Accidents | Product Liability | Malpractice | Diseases
Nursing Home Negligence | Food Poisoning | Other Topics | Social Security Disability | Contact
Statement of Clients' Rights | Site Map | Drug Injury Search | Vioxx | Mesothelioma | Permax | Dostinex | Composix Kugel Mesh X Large Patch
Ortho Evra | Fosamax | Personal Injury Lawyer | Fusarium Keratitis | Stevens Johnson Syndrome | Florida Personal Injury Law Firm

© 2002-2009 YourLawyer.com®. All Rights Reserved.

Please note that you are not considered a client until you have signed a retainer agreement and your case has been accepted by us.
Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Attorney Advertising

Parker Waichman Personal Injury News